Image-guided same-session conversion of non-tunneled central venous catheters to implantable ports through the existing venous entry: a retrospective cohort study
Background Patients with cancer may receive a non-tunneled central venous catheter (CVC) before durable access is required. We evaluated selective image-guided same-session conversion to a totally implantable venous access port (TIVAP) through the established venous entry. Methods This retrospective comparative cohort included 277 same-session transitions: 178 intended existing-entry conversions and 99 CVC removals followed by de novo ultrasound-guided venipuncture. Suspected infection, CVC-related thrombosis, or target-vein occlusion precluded conversion. The primary endpoint was procedure duration, an operational measure of procedural efficiency; fluoroscopy time was the key secondary endpoint. Propensity-score overlap weighting with 5,000 bootstrap repetitions was used. Safety outcomes were exploratory; the study was not designed for safety non-inferiority or equivalence. Results Conversion without rescue venipuncture was completed in 174/178 procedures (97.8%; exact 95% CI 94.3%–99.4%). Median procedure duration was 28.0 versus 36.0 min (adjusted mean difference −9.3 min; 95% CI −11.8 to −6.9), and fluoroscopy time was 43.0 versus 80.0 s (−36.6 s; 95% CI −46.3 to −26.8). Exploratory analyses showed shorter procedure-room time (−10.4 min; 95% CI −13.3 to −7.4) and lower reference air kerma (−18.5 mGy; 95% CI −23.3 to −13.2). Puncture-related immediate events were less frequent, whereas non-puncture procedural events were more frequent; the overall immediate-event difference was imprecise. Clinically significant 90-day TIVAP-related events occurred in 10.1% versus 13.1% (adjusted risk difference −0.8 percentage points; 95% CI −9.5 to 7.4), and 90-day infection occurred in 6.2% versus 6.1% (adjusted risk difference 1.5 percentage points; 95% CI −3.4 to 7.1). Conclusion In selected patients, image-guided existing-entry conversion avoided repeat venipuncture in nearly all intended cases and was associated with lower procedural and imaging-resource use. These findings support procedural feasibility and prospective evaluation of the selective pathway; comparative 90-day safety, particularly infection and thrombosis, remains unresolved.
Authors
- Zeyang Fan (ORCID: https://orcid.org/0000-0001-5951-8056)
- Kai Yang (ORCID: https://orcid.org/0009-0006-7028-9534)
- Xinyi Zhou
Institutions
- Fourth Hospital of Hebei Medical University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fonc.2026.1987723
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00